BOSTON SCIENTIFIC CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
BOSTON SCIENTIFIC CORPORATION (BSX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 3.01% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-19.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2019-02-19
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2018 was 3.01%, a 36.20% increase from fiscal 2017.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2017 was 2.21%, a 6.25% increase from fiscal 2016.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2016 was 2.08%, a 8.33% increase from fiscal 2015.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2015 was 1.92%, a 8.13% decline from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|
| 2018-12-31 | 3.01% 10-K · filed 2019-02-19 |
| 2017-12-31 | 2.21% 10-K · filed 2019-02-19 |
| 2016-12-31 | 2.08% 10-K · filed 2019-02-19 |
| 2015-12-31 | 1.92% 10-K · filed 2018-02-20 |
| 2014-12-31 | 2.09% 10-K · filed 2017-02-23 |
| 2013-12-31 | 1.72% 10-K · filed 2016-02-24 |
| 2012-12-31 | 1.15% 10-K · filed 2015-02-25 |
| 2011-12-31 | 2.61% 10-K · filed 2014-02-26 |
| 2010-12-31 | 2.93% 8-K · filed 2013-05-29 |
| 2009-12-31 | 3.04% 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |